Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many treatments were scheduled for review by the Clinical Priorities Advisory Group in the last review round in May 2022; how many of those scheduled were approved; and how many could not be approved as the budget had been used by higher priority treatments.

NHS England makes annual decisions on which new specialised treatments should be routinely commissioned. The decisions are based on advice from the Clinical Priorities Advisory Group, which includes of doctors, health experts and patient representatives and taken by the NHS England Board.

Treatments are grouped into five levels of priority, with those of the highest relative clinical benefit for patients and the lowest relative cost classified as level one and treatments with the lowest relative clinical benefit and highest relative cost classified as level five. The outcome of the latest prioritisation round is available at the following link:

https://www.england.nhs.uk/commissioning/spec-services/october-2022-prioritisation-decisions/